Windtree Therapeutics Inc (WINT)
1.11
+0.01
(+0.91%)
USD |
NASDAQ |
Oct 04, 16:00
1.10
-0.01
(-0.90%)
After-Hours: 20:00
Windtree Therapeutics SG&A Expense (TTM): 8.227M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 8.227M |
March 31, 2024 | 9.058M |
December 31, 2023 | 9.198M |
September 30, 2023 | 9.534M |
June 30, 2023 | 9.607M |
March 31, 2023 | 10.09M |
December 31, 2022 | 10.79M |
September 30, 2022 | 11.51M |
June 30, 2022 | 12.33M |
March 31, 2022 | 12.79M |
December 31, 2021 | 14.47M |
September 30, 2021 | 14.93M |
June 30, 2021 | 16.29M |
March 31, 2021 | 16.37M |
December 31, 2020 | 14.94M |
September 30, 2020 | 13.93M |
June 30, 2020 | 12.50M |
March 31, 2020 | 12.29M |
December 31, 2019 | 12.40M |
September 30, 2019 | 12.78M |
June 30, 2019 | 10.88M |
March 31, 2019 | 8.85M |
December 31, 2018 | 7.421M |
September 30, 2018 | 5.816M |
June 30, 2018 | 6.065M |
Date | Value |
---|---|
March 31, 2018 | 6.661M |
December 31, 2017 | 6.657M |
September 30, 2017 | 6.795M |
June 30, 2017 | 6.659M |
March 31, 2017 | 6.638M |
December 31, 2016 | 8.373M |
September 30, 2016 | 9.264M |
June 30, 2016 | 9.708M |
March 31, 2016 | 11.31M |
December 31, 2015 | 11.00M |
September 30, 2015 | 12.53M |
June 30, 2015 | 14.60M |
March 31, 2015 | 15.66M |
December 31, 2014 | 16.73M |
September 30, 2014 | 17.06M |
June 30, 2014 | 17.24M |
March 31, 2014 | 16.92M |
December 31, 2013 | 16.72M |
September 30, 2013 | 19.18M |
June 30, 2013 | 19.14M |
March 31, 2013 | 18.62M |
December 31, 2012 | 16.44M |
September 30, 2012 | 11.80M |
June 30, 2012 | 9.735M |
March 31, 2012 | 8.091M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
8.227M
Minimum
Jun 2024
16.37M
Maximum
Mar 2021
12.17M
Average
12.33M
Median
Jun 2022
SG&A Expense (TTM) Benchmarks
ANI Pharmaceuticals Inc | 187.31M |
AIM ImmunoTech Inc | 22.70M |
Perspective Therapeutics Inc | 18.64M |
Protalix BioTherapeutics Inc | 14.41M |
Armata Pharmaceuticals Inc | 13.38M |